Kintara Therapeutics Inc (KTRA)
0.1751
+0.03
(+20.68%)
USD |
NASDAQ |
May 20, 15:49
Kintara Therapeutics Total Liabilities (Quarterly): 1.524M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.524M |
December 31, 2023 | 2.049M |
September 30, 2023 | 3.503M |
June 30, 2023 | 3.248M |
March 31, 2023 | 2.954M |
December 31, 2022 | 3.319M |
September 30, 2022 | 3.592M |
June 30, 2022 | 4.153M |
March 31, 2022 | 3.412M |
December 31, 2021 | 3.616M |
September 30, 2021 | 3.18M |
June 30, 2021 | 2.962M |
March 31, 2021 | 2.735M |
December 31, 2020 | 2.904M |
September 30, 2020 | 2.577M |
June 30, 2020 | 2.675M |
March 31, 2020 | 1.382M |
December 31, 2019 | 1.027M |
September 30, 2019 | 1.339M |
June 30, 2019 | 2.070M |
March 31, 2019 | 1.198M |
December 31, 2018 | 1.268M |
September 30, 2018 | 1.079M |
June 30, 2018 | 1.640M |
March 31, 2018 | 2.017M |
Date | Value |
---|---|
December 31, 2017 | 2.232M |
September 30, 2017 | 1.529M |
June 30, 2017 | 1.332M |
March 31, 2017 | 1.111M |
December 31, 2016 | 0.8922M |
September 30, 2016 | 1.073M |
June 30, 2016 | 1.497M |
March 31, 2016 | 1.843M |
December 31, 2015 | 2.068M |
September 30, 2015 | 3.546M |
June 30, 2015 | 3.397M |
March 31, 2015 | 2.196M |
December 31, 2014 | 2.042M |
September 30, 2014 | 3.976M |
March 31, 2014 | 6.814M |
December 31, 2013 | 5.137M |
September 30, 2013 | 5.697M |
June 30, 2013 | 14.23M |
March 31, 2013 | 9.712M |
December 31, 2012 | 0.0196M |
September 30, 2012 | 0.013M |
June 30, 2012 | 0.01M |
March 31, 2012 | 0.01M |
December 31, 2011 | 0.0049M |
September 30, 2011 | 0.00 |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.027M
Minimum
Dec 2019
4.153M
Maximum
Jun 2022
2.711M
Average
2.929M
Median
Total Liabilities (Quarterly) Benchmarks
ARCA biopharma Inc | 1.581M |
Shockwave Medical Inc | 891.99M |
Vanda Pharmaceuticals Inc | 108.69M |
Heron Therapeutics Inc | 251.65M |
Asensus Surgical Inc | 27.79M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 7.446M |
Shareholders Equity (Quarterly) | 5.922M |